On April 17, the Supreme Judicial Court agreed with the
Massachusetts Bar Association and Massachusetts Medical Society
when it affirmed a $63 million Children's Motrin verdict in a case
where a young child developed toxic epidermal necrolysis after
receiving multiple doses of the over-the-counter painkiller. The
SJC found that Johnson & Johnson's warning claim is not
preempted and that the awards for the victim and her parents were
To see the amicus brief filed on behalf of the MBA and Mass. Medical Society, click here.